Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Neoadjuvant chemotherapy with FOLFOX: improved outcomes in Chinese patients with locally advanced gastric cancer.

Li ZY, Koh CE, Bu ZD, Wu AW, Zhang LH, Wu XJ, Wu Q, Zong XL, Ren H, Tang L, Zhang XP, Li JY, Hu Y, Shen L, Ji JF.

J Surg Oncol. 2012 Jun 15;105(8):793-9. doi: 10.1002/jso.23009. Epub 2011 Dec 20.

PMID:
22189752
2.

[FOLFOX regimen in the patients with locally advanced or metastatic gastric cancer].

Yan D, Dai H.

Zhonghua Zhong Liu Za Zhi. 2009 Mar;31(3):217-9. Chinese.

PMID:
19615264
3.

Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.

Lorenzen S, Blank S, Lordick F, Siewert JR, Ott K.

Ann Surg Oncol. 2012 Jul;19(7):2119-27. doi: 10.1245/s10434-012-2254-1. Epub 2012 Mar 7.

PMID:
22395980
5.

Thymidylate synthase protein expression: Association with response to neoadjuvant chemotherapy and resection for locally advanced gastric and gastroesophageal adenocarcinoma.

Alexander HR, Grem JL, Hamilton JM, Pass HI, Hong M, Fraker DL, Steinberg SM, McAtee N, Allegra BC, Johnston PG.

Cancer J Sci Am. 1995 May-Jun;1(1):49-54.

PMID:
9166454
6.

[Palliative surgery combined with oxaliplatin-based chemotherapy in treatment of patients with advanced gastric cancer].

Chen YB, Guan YX, Zhan YQ, Li W, Sun XW, Li YF, Xu DZ.

Ai Zheng. 2004 Nov;23(11 Suppl):1520-2. Chinese.

PMID:
15566671
7.

[A prospective study of FOLFOX7 scheme as neoadjuvant chemotherapy for stage III gastric adenocarcinoma].

Liu YH.

Zhonghua Wai Ke Za Zhi. 2009 Sep 1;47(17):1305-8. Chinese.

PMID:
20092724
8.

Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4.

el Aziz LM.

Med Oncol. 2014 Dec;31(12):311. doi: 10.1007/s12032-014-0311-2. Epub 2014 Nov 4.

PMID:
25367855
9.

Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.

Persiani R, D'Ugo D, Rausei S, Sermoneta D, Barone C, Pozzo C, Ricci R, La Torre G, Picciocchi A.

J Surg Oncol. 2005 Mar 15;89(4):227-36; discussion 237-8.

PMID:
15726615
10.

Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma.

Ruf C, Thomusch O, Goos M, Makowiec F, Illerhaus G, Ruf G.

BMC Surg. 2014 Jan 24;14:5. doi: 10.1186/1471-2482-14-5.

12.

[Treatment of advanced gastric cancer with oxaliplatin plus 5-fluorouracil/ leucovorin (FOLFOX-4 chemotherapy)].

Garrido M, Melgoza G, Galindo H, Madrid J, Sánchez C, Nervi B, Alvarez M, Orellana E.

Rev Med Chil. 2007 Nov;135(11):1380-7. doi: /S0034-98872007001100003. Epub 2008 Jan 16. Spanish.

13.

Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?

Mansour JC, Tang L, Shah M, Bentrem D, Klimstra DS, Gonen M, Kelsen DP, Brennan MF, Coit DG.

Ann Surg Oncol. 2007 Dec;14(12):3412-8. Epub 2007 Oct 2.

PMID:
17909917
14.

Treatment of locally advanced gastric cancer with the XELOX program of neoadjuvantchemotherapy combined with laparoscopic surgery: the experience in China.

Zheng CH, Lu J, Huang CM, Li P, Xie JW, Wang JB, Lin JX.

Hepatogastroenterology. 2014 Oct;61(135):1876-82.

PMID:
25713882
15.

Neoadjuvant chemotherapy versus surgery alone for locally advanced gastric cancer: a retrospective comparative study.

Wang LB, Shen JG, Xu CY, Chen WJ, Song XY, Yuan XM.

Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1895-8.

PMID:
19102417
16.

DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.

Ott K, Rachakonda PS, Panzram B, Keller G, Lordick F, Becker K, Langer R, Buechler M, Hemminki K, Kumar R.

Ann Surg Oncol. 2011 Sep;18(9):2688-98. doi: 10.1245/s10434-011-1601-y. Epub 2011 Feb 24.

PMID:
21347786
17.
18.

[Neoadjuvant chemotherapy for locally advanced gastric cancer].

Kalmár K, Cseke L, Káposztás Z, Horváth G, Varga E.

Magy Seb. 2003 Oct;56(5):177-84. Hungarian.

PMID:
15022621
19.

Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.

Ott K, Sendler A, Becker K, Dittler HJ, Helmberger H, Busch R, Kollmannsberger C, Siewert JR, Fink U.

Gastric Cancer. 2003;6(3):159-67.

PMID:
14520529
20.

[Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response].

Káposztás Z, Cseke L, Kalmár K, Horváth OP.

Magy Seb. 2002 Oct;55(5):321-4. Review. Hungarian.

PMID:
12474518

Supplemental Content

Support Center